HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.

Abstract
During pregnancy, the ETS transcription factor ELF5 establishes the milk-secreting alveolar cell lineage by driving a cell fate decision of the mammary luminal progenitor cell. In breast cancer, ELF5 is a key transcriptional determinant of tumor subtype and has been implicated in the development of insensitivity to anti-estrogen therapy. In the mouse mammary tumor virus-Polyoma Middle T (MMTV-PyMT) model of luminal breast cancer, induction of ELF5 levels increased leukocyte infiltration, angiogenesis, and blood vessel permeability in primary tumors and greatly increased the size and number of lung metastasis. Myeloid-derived suppressor cells, a group of immature neutrophils recently identified as mediators of vasculogenesis and metastasis, were recruited to the tumor in response to ELF5. Depletion of these cells using specific Ly6G antibodies prevented ELF5 from driving vasculogenesis and metastasis. Expression signatures in luminal A breast cancers indicated that increased myeloid cell invasion and inflammation were correlated with ELF5 expression, and increased ELF5 immunohistochemical staining predicted much shorter metastasis-free and overall survival of luminal A patients, defining a group who experienced unexpectedly early disease progression. Thus, in the MMTV-PyMT mouse mammary model, increased ELF5 levels drive metastasis by co-opting the innate immune system. As ELF5 has been previously implicated in the development of antiestrogen resistance, this finding implicates ELF5 as a defining factor in the acquisition of the key aspects of the lethal phenotype in luminal A breast cancer.
AuthorsDavid Gallego-Ortega, Anita Ledger, Daniel L Roden, Andrew M K Law, Astrid Magenau, Zoya Kikhtyak, Christina Cho, Stephanie L Allerdice, Heather J Lee, Fatima Valdes-Mora, David Herrmann, Robert Salomon, Adelaide I J Young, Brian Y Lee, C Marcelo Sergio, Warren Kaplan, Catherine Piggin, James R W Conway, Brian Rabinovich, Ewan K A Millar, Samantha R Oakes, Tatyana Chtanova, Alexander Swarbrick, Matthew J Naylor, Sandra O'Toole, Andrew R Green, Paul Timpson, Julia M W Gee, Ian O Ellis, Susan J Clark, Christopher J Ormandy
JournalPLoS biology (PLoS Biol) Vol. 13 Issue 12 Pg. e1002330 (Dec 2015) ISSN: 1545-7885 [Electronic] United States
PMID26717410 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • ELF5 protein, human
  • Neoplasm Proteins
  • Proto-Oncogene Proteins c-ets
  • Recombinant Fusion Proteins
  • Transcription Factors
  • enhanced green fluorescent protein
  • Green Fluorescent Proteins
Topics
  • Animals
  • Breast Neoplasms (immunology, metabolism, physiopathology, virology)
  • Capillary Permeability
  • Cell Proliferation
  • DNA-Binding Proteins
  • Female
  • Green Fluorescent Proteins (genetics, metabolism)
  • Hemorrhage (etiology, prevention & control)
  • Humans
  • Leukocytes (immunology, pathology)
  • Lung (blood supply, immunology, metabolism, pathology)
  • Lung Neoplasms (blood supply, pathology, prevention & control, secondary)
  • Lymphocyte Depletion
  • Mice, Transgenic
  • Myeloid Cells (immunology, pathology)
  • Neoplasm Proteins (genetics, metabolism)
  • Neovascularization, Pathologic (etiology, prevention & control)
  • Neutrophil Infiltration
  • Polyomavirus (pathogenicity)
  • Proto-Oncogene Proteins c-ets (genetics, metabolism)
  • Recombinant Fusion Proteins (metabolism)
  • Survival Analysis
  • Transcription Factors
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: